Skip to main content


Matthias Paireder
Matthias Paireder, MD

Department of General Surgery (Division of Visceral Surgery)
Position: Consultant

ORCID: 0000-0001-7119-8454

Further Information


Barrett Esophagus; Esophageal Neoplasms; Oncology; Upper Gastrointestinal Tract


  • ACO ASSO Publication Award (2017)
    Source of Funding: Austrian Society of Surgical Oncology, Award
    Principal Investigator
  • Fellowship of Surgical Oncology (2014)
    Source of Funding: Austrian Society of Surgical Oncology, Ingrid Shaker-Nessmann Cancer Research Association
    Principal Investigator

Selected publications

  1. Paireder, M. et al., 2020. Modification of preoperative radiochemotherapy for esophageal cancer (CROSS protocol) is safe and efficient with no impact on surgical morbidity. Strahlentherapie und Onkologie. Available at:
  2. Paireder, M. et al., 2019. Electrical lower esophageal sphincter augmentation in patients with GERD and severe ineffective esophageal motility—a safety and efficacy study. Surgical Endoscopy, 33(11), pp.3623–3628. Available at:
  3. Paireder, M. et al., 2017. External validation of the NUn score for predicting anastomotic leakage after oesophageal resection. Scientific Reports, 7(1). Available at:
  4. Paireder, M. et al., 2017. Impact of sarcopenia on outcome in patients with esophageal resection following neoadjuvant chemotherapy for esophageal cancer. European Journal of Surgical Oncology (EJSO), 43(2), pp.478–484. Available at:
  5. Paireder, M. et al., 2018. Morbidity in open versus minimally invasive hybrid esophagectomy (MIOMIE). European Surgery, 50(6), pp.249–255. Available at: